Ibandroninezuur (Bondronat®), preventie van botproblemen bij gemetastaseerd mammacarcinoom


1. Body J-J, et al. Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. Br J Cancer 2004; 90: 1133-1137. 
2. EPAR Bondronat, EMEA, London, 2004 (www.emea.eu.int/index/indexh1.htm [human medicines].
3. Body J-J, et al. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain 2004; 111:306-312.
4. Productinformatie ibandroninezuur (Bondronat®) via: www.emea.eu.int/index/indexh1.htm , EPARs.
5. Pavlakis N, et al. Bisphosphonates for most cancer. In: The Cochrane Library, Issue 1, 2004. Chishester, UK: John Wiley & Sons, Ltd. 

Auteurs

  • dr J.J. Beckeringh